{
    "nctId": "NCT04690439",
    "briefTitle": "Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema",
    "officialTitle": "Evaluating the Effectiveness of Photobiomodulation Therapy in the Management of Breast Cancer-Related Lymphedema: a Randomized Controlled Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Breast Cancer Related Lymphedema, Lymphedema of Upper Arm",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 104,
    "primaryOutcomeMeasure": "Arm circumference and volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosed with breast cancer\n* Underwent ipsilateral lumpectomy or mastectomy + sentinel lymph node biopsy +/- lymph node dissection\n* Underwent radiotherapy with or without chemotherapy\n* Diagnosed with BCRL (i.e. International Society of Lymphology (ISL) lymphedema stage I or higher)\n* Age \u2265 18 years\n* Able to comply to the study protocol\n* Able to sign written informed consent\n\nExclusion Criteria:\n\n* Metastatic disease\n* Pregnancy\n* History of surgery or trauma to the arm\n* History of arm infection in the past 3 months\n* Use of medications that affect body fluid (e.g., diuretics) in the last 3 months\n* Severe psychological disorder or dementia\n* Any condition that is unstable or could affect the safety of the patient and their compliance in the study as judged by the investigator",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}